For research purposes only — These compounds aren't FDA approved. All data presented is from clinical trials for educational reference.
GLOW
Regenerative Peptide Blend
Dosage
Quantity
Price
$103.49
Free shipping on orders $150+
60-day money-back guarantee
Secure checkout
Made in the USA
Certificate of Analysis
Batch verified lab data
99.93%
Purity
- Variant
- GLOW 70mg (10 + 10 + 50)
- Lot #
- A0112
- Labeled
- 20mg
- Actual
- 22.56mg
- Tested
- Feb 4, 2026
Frequently Researched Together
View allResearch Purposes Snapshot
GLOW combines BPC-157, TB-500, and GHK-Cu. Below summarizes what is reported for each ingredient in isolation; dedicated large-scale human trials on this exact blend are scarce. Not FDA approved for therapeutic use.
Researcher notes
- Each ingredient carries different regulatory baggage—cosmetic history for GHK-Cu vs investigational peptides.
- Combination products need their own stability and safety characterization beyond single-compound files.
- Map every bullet below to primary literature; synergy language is mechanistic, not a substitute for combo RCTs.
500+
Combined literature
Hundreds of indexed studies across the three ingredients; true blend trials remain limited.
3
Pathway layers
Angiogenic (VEGFR2), actin motility, and collagen/ECM programs are commonly discussed together.
70%
GHK-Cu collagen
Collagen synthesis increases vs controls in skin-focused research summaries.
61%
TB-500 closure
Faster re-epithelialization vs controls at day 7 in cited wound models.
7×
BPC-157 GHR
Growth hormone receptor upregulation by day 3 in fibroblast reports.
Blend rationale
Why researchers discuss stacking
Animal models suggest parallel engagement of vascular, motility, and matrix programs—useful for hypothesis generation, not clinical proof of this SKU.
- BPC-157
- 200+ pubs
- Angiogenesis / fibroblast support
- TB-500
- 170+ pubs
- Actin organization & migration
- GHK-Cu
- 130+ pubs
- Collagen & gene-expression shifts
GHK-Cu review landscape includes MDPI-style summaries—verify statistics in originals.
Observed in component studies
Headline metrics (not blend RCTs)
Fold-change readouts from fibroblast/tendon models—see primary figures.
- GHK-Cu + PIC models: up to ~9× collagen improvement in select wound papers.
- BPC-157: recurring 7× GHR signal in tendon fibroblast work.
- TB-500: 61% faster epithelial resurfacing vs controls at one-week readouts.
Applications cited in reviews
Where literature focuses
- Skin regeneration — GHK-Cu drives collagen programs; BPC-157/TB-500 support epithelial repair (Pickart & Margolina, 2018).
- Soft tissue repair — TB-500 actin remodeling, BPC-157 fibroblast viability, GHK-Cu vascular stabilization (Chi et al., 2017).
- Inflammation control — parallel anti-inflammatory motifs with distinct receptors (Hsieh et al., 2016).
- ECM remodeling — coordinated matrix deposition vs fibrosis (Brcic et al., 2011).
Neurovascular interface
Peripheral nerve and perfusion papers attribute complementary roles: TB-500/BPC-157 for endothelial scaffolding, GHK-Cu/BPC-157 for microvascular expansion, with perfusion supported by all three in review narratives.
Gwyer et al., 2019.
Dermatologic remodeling
Preclinical skin models emphasize collagen synthesis, broad gene-expression shifts, wrinkle-depth reductions, and thickness gains in aged tissue analogs.
- Collagen ↑ ~70%
- 4,000+ genes referenced in GHK-Cu summaries
- Clinical facial data cited for wrinkle metrics
Musculoskeletal repair
Soft-tissue injury models quote additive migration/angiogenesis readouts when ingredients are studied separately.
- TB-500 migration ≈ +85%
- BPC-157 angiogenesis ≈ +80%
- GHK-Cu vascularization ≈ +75%
Seiwerth et al., 2018.
Protective & anti-inflammatory
GHK-Cu chelates free copper and may downregulate TNF-α/IL-6; BPC-157 stabilizes nitric oxide tone; TB-500 shifts macrophage behavior in animal models.
3× pathway diversity
Net effect described as a moderated inflammatory milieu conducive to remodeling (PMC GHK-Cu reviews).
Safety profile from research
Component-level tolerability; combination data still thin.
Frequently cited mild events
Injection site
Mild0%
Systemic toxicity signal
Not observed in component preclinical reviews cited.
Per-ingredient snapshot
- BPC-157: no classical LD50 in standard rodent tox panels.
- TB-500: generally well tolerated in published animal work.
- GHK-Cu: long cosmetic-use history; still research-grade when repackaged for labs.
Regulatory & ethics flags
- Research use only — not an FDA-cleared therapy.
- WADA lists BPC-157 and TB-500 (S0); verify athlete policies independently.
- Pregnancy, lactation, and pediatric dosing lack controlled blend data.
Compound information
Technical snapshot by ingredient
What's in the blend
- BPC-157 — 15 aa, ~1.42 kDa class size
- TB-500 — 43 aa fragment of thymosin β4, ~4.96 kDa class size
- GHK-Cu — tripeptide + Cu²⁺, ~403 Da class size
Confirm exact masses on PubChem / vendor CoA.
Stability & handling
- Lyophilized powder: store ≤−20°C for long holds.
- After reconstitution: 2–8°C and use within ~7 days unless stability data says otherwise.
- Protect from light; minimize freeze-thaw by aliquoting.
Literature maturity
- BPC-157 — deep preclinical archive
- TB-500 — preclinical + limited human analog context
- GHK-Cu — cosmetic + bench crossover
- Fixed-ratio blends — emerging, not canonical
PubMed searches per ingredient outperform vague “stack” queries.
Storage handling reference
Peptide handling
Freeze
Powder: −20°C or colder.
Refrigerate
Liquid: 2–8°C after reconstitution.
Light
Limit photodegradation during prep.
Aliquot
Single-use vials reduce oxidation.
Important Research Notice
Not for human consumption. This product and all products are sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from journals and official publications but should be fact checked. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations and you do not intend to use it for human consumption.